Medtronic targets $1B cardiovascular growth in FY25 with PFA expansion
Q3 2025 Management View CEO Geoff Martha highlighted mid-single-digit revenue growth for the ninth consecutive quarter, driven by strong performances in cardiac ablation solutions, leadless pacing, ...
Business Wire2mon
MedLumics is Proud to Announce the Completion of the FIM Study, With Successful Remapping at 3 Months, Demonstrating the Efficacy of the AblaView® Optically Guided Pulsed ...
MADRID--(BUSINESS WIRE)--“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm ...